AdventHealth offers leading-edge treatment using plasma from recovered COVID-19 patients

Published date: |
Estimated read time: |
Authored by:
  • AdventHealth
AdventHealth logo
Choose the health content that's right for you, and get it delivered right in your inbox

ORLANDO, Fla., April 8, 2020 — Patients with severe cases of COVID-19 may find help in an unlikely source – the blood plasma of patients who’ve recovered from the disease.

It’s called convalescent plasma, and the idea is that antibodies in the donated plasma will help fight the disease in patients who are suffering through it.

“This is an extremely exciting development that shows promise in helping our sickest patients,” said Dr. Juliana Gaitan, who is leading the project. “We’re among the first hospitals in the country to begin offering this therapy.”

The U.S. Food & Drug Administration is facilitating access to the COVID-19 convalescent plasma for use in patients with serious or immediately life-threatening infections.

AdventHealth is working with OneBlood to solicit donations from recovered patients across the region. OneBlood will collect the plasma, which can be collected either from whole-blood or plasma-only donors.

Recovered patients who are at least 15 days out from experiencing symptoms are eligible to donate.

“We are really depending on the community for support,” said Dr. Gaitan. “As the number of COVID-19 cases increases, we expect high demand for this potentially lifesaving treatment.”

Prospective donors can get more information here: https://www.oneblood.org/lp/covid-19-convalescent-plasma.stml#btndonate

Recent News

View More Articles